Thoracic aortic aneurysm (TAA) represents a major cause of mortality and morbidity in
Western countries. The natural history of TAA is indolent, with patients usually being …

BACKGROUND: Thoracic aortic aneurysms (TAAs) develop through an asymptomatic
process resulting in gross dilation that progresses to rupture if left undetected and untreated …

Thoracic aortic aneurysm (TAA) is a silent disease, often discovered at a time point that
dramatic complications, as rupture and dissection, occur. For the detection of asymptomatic …

Thoracic aortic aneurysm (TAA) develops silently and asymptomatically and is a major
cause of mortality. TAA prevalence is greatly underestimated, it is usually diagnosed …

Background Thoracic aortic aneurysm (TAA) is usually asymptomatic and associated with
high mortality. Adverse clinical outcome of TAA is preventable by elective surgical repair; …

Background: There is a need for clinical markers to aid in the detection of individuals at risk
of harboring an ascending thoracic aneurysm (ATAA) or developing one in the future …

Thoracic aortic aneurysms (TAAs) and aortic dissections (ADs) are among the main causes
of mortality and morbidity in Western countries. For this reason, the diagnosis, prevention …

Thoracic aortic aneurysms (TAAs) are a pathological widening of the aorta in the thorax.
TAAs, which are clinically silent, are caused by vascular wall weakness predisposing …

The main challenge in diagnosing and managing thoracic aortic aneurysm and dissection
(TAA/D) is represented by the early detection of a disease that is both deadly and “elusive” …

The expansion in the repertoire of genes linked to thoracic aortic aneurysms (TAA) has
revolutionised our understanding of the disease process. The clinical benefits of such …